Reference
European Medicines Agency. PRAC recommends further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate medicine. Internet Document : [2 pages], 13 Mar 2015. Available from: URL: http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2015/03/WC500184259.pdf
Rights and permissions
About this article
Cite this article
EMA offers ways to minimise jaw osteonecrosis with Aclasta. Reactions Weekly 1544, 2 (2015). https://doi.org/10.1007/s40278-015-8849-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-8849-0